1. Home
  2. UMH vs GKOS Comparison

UMH vs GKOS Comparison

Compare UMH & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UMH

UMH Properties Inc.

HOLD

Current Price

$15.92

Market Cap

1.4B

Sector

Real Estate

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$116.63

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UMH
GKOS
Founded
1968
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
5.4B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
UMH
GKOS
Price
$15.92
$116.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
13
Target Price
$17.75
$126.38
AVG Volume (30 Days)
618.2K
735.2K
Earning Date
11-03-2025
10-29-2025
Dividend Yield
5.67%
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$256,272,000.00
$469,820,000.00
Revenue This Year
$10.80
$31.15
Revenue Next Year
$8.34
$24.15
P/E Ratio
$202.34
N/A
Revenue Growth
8.96
30.38
52 Week Low
$13.95
$73.16
52 Week High
$19.14
$163.71

Technical Indicators

Market Signals
Indicator
UMH
GKOS
Relative Strength Index (RSI) 58.86 74.84
Support Level $15.58 $115.07
Resistance Level $16.39 $118.17
Average True Range (ATR) 0.28 3.10
MACD -0.00 0.01
Stochastic Oscillator 64.56 87.55

Price Performance

Historical Comparison
UMH
GKOS

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: